Starting antiretroviral treatment earlier doesn’t negatively impact adherence and disclosure
People who start antiretroviral treatment early, regardless of their CD4 count, are just as likely to stick to their treatment plan as those who begin their treatment when their CD4 count is low. The mixed methods paper led by the Amsterdam Institute for Global Health and...